The FDA recently issued a warning letter jointly with the Federal Trade Commission to Alternative Health Distribution LLC d/b/a CannaAid for selling unapproved and misbranded products for use in treating or preventing COVID-19. Consumers concerned about COVID-19 should consult with their health care provider.
FDA is actively monitoring for any firms marketing products with fraudulent COVID-19 prevention and treatment claims.
FDA's Health Fraud Product Database includes only a small fraction of the potentially dangerous products marketed to consumers online and in stores. Even if a product is not included in this list, consumers should exercise caution before using these types of products.